ITIF：2025年跟进生物制药创新对健康结果和经济增长的价值报告（英文版）

Biopharmaceutical innovation represents cumulative progress: Each innovation builds on earlier ones. Follow-on innovations are key in this process, refining, optimizing, and adding to first-in-class innovations to improve efficacy, safety, and access.  Accounting for a substantial share of innovations in key therapeutic areas, follow-on innovations create better formulations and dosage forms of existing therapies or broaden their therapeutic applications to new indications and patient popula